問卷

TPIDB > Principal Investigator

Principal Investigator


Chi Mei Medical Center (在職)

Division of Dermatology

更新時間:2023-09-19

賴豐傑
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2011-07-01 - 2015-07-31

Phase III

A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trail to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients with Actinic Keratosis
  • Condition/Disease

    Actinic Keratosis

  • Test Drug

    SR-T100

Participate Sites
6Sites

Terminated6Sites

2013-11-29 - 2013-11-29

Phase II

A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.
  • Condition/Disease

    Common Warts / Verruca Vulgaris (CWs)

  • Test Drug

    SR-T100

Participate Sites
4Sites

Study ended4Sites

2021-09-01 - 2022-11-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Recruiting10Sites

Terminated2Sites